SEC Form 4 · accession 0001628280-16-017478
SCYNEXIS INC · SCYX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gonzalez David Angulo
Officer — Chief Medical Officer
Period of report
Jun 29, 2016
Accepted (ET)
Jul 1, 2016 · 10:31 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 29, 2016 | P | 4,800 | $2.18 | A | 8,850 | D | |
| Common StockF1 | Jun 30, 2016 | P | 32,150 | $2.23 | A | 41,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.19 to $2.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.